可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Amsterdam EA,Wenger NK,Brindis RG,et al.2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2014,64(24):139-228.
[2]O’Gara PT,Kushner FG,Aschein DD,et al.2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J].J Am Coll Cardiol,2013,61(4):e78-e140.
[3]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2014》概要[J].中国循环杂志,2015,30(7): 617-622.
[4]Fox KA,FitzGerald G,Puymirat E,et al.Should patients with acute coronary disease be stratified for management according to their risk? Derivation,external validation and outcomes using the updated GRACE risk score[J].BMJ Open,2014,4(2):e004425.
[5]Fox KA,Dabbous OH,Goldberg RJ,et al.Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study(GRACE)[J].BMJ,2006,333(7578):1091.
[6]Granger CB,Goldberg RJ,Dabbous O,et al.Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events[J].Arch Intern Med,2003,163(19):2345-2353.
[7]Vesely MR,Kelemen MD.Cardiac risk assessment:matching intensity of therapy to risk[J].Cardiol Clin,2006,24(1):67-78.
[8]Steg PG,Goldberg RJ,Gore JM,et al.Baseline characteristics,management practices,and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events(GRACE)[J].Am J Cardiol,2002,90(4):358-363.
[9]Ji CL,Zhou HR,Peng CH,et al.Comparison of value of GRACE, APACHEII and REMS for early prognosis of death in patients with acute myocardial infarction[J].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2013.25(11): 660-663.
[10]Lichtman JH,Spertus JA,Reid KJ,et al.Acute noncardiac conditions and in-hospital mortality in patients with acute myocardial infarction[J].Circulation,2007,116(17):1925-1930.
[11]Brieger D,Fox KA,FitzGerald G,et al.Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes:the Global Registry of Acute Coronary Events[J].Heart,2009,95(11):888-894.
[12]Kelly A,Dabee P,Klim S,et al.External validation of the GRACE Freedom from Events score[J].Heart Lung Circ,2012,21(9):582-585.
[13]Kelly AM,Klim S,Soon K.External validation of the GRACE Freedom from Events score in an emergency department‘rule out ACS’chest pain cohort[J].Int J Cardiol,2015,179:358-359.
[14]Huang W,FitzGerald G,Goldberg RJ,et al.Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort[J].Am J Cardiol,2016,118(8): 1105-1110.
[15]Akyuz S,Yazici S,Bozbeyoglu E,et al.Validity of the updated GRACE risk predictor(version 2.0)in patients with non-ST-elevation acute coronary syndrome[J].Rev Port Cardiol,2016,35(1):25-31.
[16]Zhou D,Fan Y,Wan Z,et al.Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome[J].Cardiology,2016,134(1):39-46.
[17]Parenica J,Kala P,Pavkova MG,et al.Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study[J].Int J Cardiol,2016,211:96-104.
[18]Timoteo AT,Papoila AL,Rio P,et al.Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes:added value on top of GRACE risk score[J].Eur HeartJ Acute Cardiovasc Care,2014,3(3):257-263.
[19]Yan S,Liu X,Peng Y,et al.Admission Serum Calcium Levels Improve the GRACE Risk Score Prediction of Hospital Mortality in Patients With Acute Coronary Syndrome[J].Clinical Cardiology,2016,39(9):516-523.
[20]McNamara RL,Kennedy KF,Cohen DJ,et al.Predicting in-hospital mortality in patients with acute myocardial infarction[J].J Am Coll Cardiol,2016,68(6):626-635.
[21]Mahler SA,Riley RF,Hiestand BC,et al.The HEART Pathway randomized trial:identifying emergency department patients with acute chest pain for early discharge[J].Circ Cardiovasc Qual Outcomes,2015,8(2):195-203.
[22]Yeh RW,Secemsky EA,Kereiakes DJ,et al.Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention[J].JAMA,2016,315(16):1735-1749.